5-methylcytosine has been researched along with Lymphoma, B-Cell in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carll, TC; Chiu, BC; Kline, J; Riedell, P; Smith, S; Tanager, KS; Tatarian, AH; Venkataraman, G; Yu, J | 1 |
| Hirota, S; Imai, Y; Matsuda, I | 1 |
| Aifantis, I; Aranda-Orgilles, B; Bakogianni, S; Bhattacharyya, S; Cimmino, L; Dawlaty, MM; Geng, H; Jaenisch, R; King, B; Liu, C; Lobry, C; Mullenders, J; Ndiaye-Lobry, D; Shaknovich, R; Shen, S; Trimarchi, T; Verma, AK; Yap, YS; Yu, Y | 1 |
| Ambinder, RF; Gulley, ML; Manns, A; Robertson, KD; Swinnen, LJ; Zong, JC | 1 |
4 other study(ies) available for 5-methylcytosine and Lymphoma, B-Cell
| Article | Year |
|---|---|
Loss of 5-hydroxymethylcytosine expression is near-universal in B-cell lymphomas with variable mutations in epigenetic regulators.
Topics: 5-Methylcytosine; Epigenesis, Genetic; Humans; Lymphoma, B-Cell; Mutation | 2022 |
Distinct global DNA methylation status in B-cell lymphomas: immunohistochemical study of 5-methylcytosine and 5-hydroxymethylcytosine.
Topics: 5-Methylcytosine; Adolescent; Adult; Aged; Aged, 80 and over; Cytosine; DNA Methylation; Epigenesis, Genetic; Epigenomics; Female; Humans; Immunohistochemistry; Lymphoma, B-Cell; Male; Middle Aged; Young Adult | 2014 |
TET1 is a tumor suppressor of hematopoietic malignancy.
Topics: 5-Methylcytosine; Animals; B-Lymphocytes; Cell Differentiation; Cell Lineage; Chromosomal Instability; Cytosine; DNA Methylation; DNA Repair; DNA-Binding Proteins; Embryonic Stem Cells; Epigenesis, Genetic; Exome; Gene Expression Profiling; Humans; Lymphoma, B-Cell; Mice; Mutation; Proto-Oncogene Proteins; Tumor Suppressor Proteins | 2015 |
CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's disease.
Topics: 5-Methylcytosine; Anemia, Aplastic; Burkitt Lymphoma; CpG Islands; Cytosine; DNA (Cytosine-5-)-Methyltransferases; DNA-Binding Proteins; DNA, Neoplasm; DNA, Viral; Epstein-Barr Virus Nuclear Antigens; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Viral; Ghana; Herpesviridae Infections; Herpesvirus 4, Human; Hodgkin Disease; Immunocompromised Host; Immunodominant Epitopes; Immunologic Surveillance; Lymphoma, B-Cell; Methylation; Neoplasm Proteins; Promoter Regions, Genetic; Tumor Virus Infections; Virus Latency | 1996 |